PRESS RELEASE Zurich, Switzerland, January 9, 2025 – MUVON Therapeutics AG, an innovative clinical-stage biotechnology company, will attend the 43rd annual J.P. Morgan Healthcare conference to highlight plans advancing its lead program. MUVON Therapeutics, an award-winning, clinical-stage biotechnology company focused on developing a novel platform for the regeneration of …
